Datum Källa Rubrik Typ Alternativ
2021-02-11 Genovis Genovis AB: Bokslutskommuniké 2020 Rapporter Ladda ner | Visa Stäng
2021-02-11 Genovis Genovis AB: Year-end Report January - December 2020 Rapporter Ladda ner | Visa Stäng
2020-12-10 Genovis Genovis AB: Genovis and Glykos partner to enable new ADC platform Pressreleaser Ladda ner | Visa Stäng
2020-12-10 Genovis Genovis AB: Genovis inleder samarbete med Glykos och erbjuder ny plattform för ADC Pressreleaser Ladda ner | Visa Stäng
2020-11-05 Genovis Genovis AB: Delårsrapport för det tredje kvartalet 2020 Rapporter Ladda ner | Visa Stäng
2020-11-05 Genovis Genovis AB: Report for the third quarter of 2020 Rapporter Ladda ner | Visa Stäng
2020-08-13 Genovis Genovis AB: Halvårsrapport januari - juni 2020 Rapporter Ladda ner | Visa Stäng
2020-08-13 Genovis Genovis AB: Half-Yearly Report January - June 2020 Rapporter Ladda ner | Visa Stäng
Rapporter | 13 Aug 2020 | Genovis

Genovis AB: Half-Yearly Report January – June 2020

April – June in brief

  • Net sales rose by 35 percent to SEK 15,490 (11,509) thousand. Adjusted for acquired sales, growth rose by 11% to SEK 12,714 thousand.
  • Gross profit/loss improved by SEK 978 thousand and totaled SEK 13,146 (12,168) thousand.
  • Operating result before depreciation and amortization (EBITDA) totaled SEK -38 (2,390) thousand and was negatively impacted by non-recurring items for acquisitions and restructuring costs of SEK 1 million.
  • Operating result totaled SEK -1,291 (1,628) thousand.
  • Comprehensive income for the period totaled SEK -3,124 (1,380) thousand.
  • Comprehensive income per share, basic and diluted, totaled SEK -0.05 (0.02).
  • Cash flow from operating activities was SEK -123 (profit: 145) thousand.
  • Cash and cash equivalents at the end of the period totaled SEK 46,554 (8,921) thousand.
  • Genovis has acquired all shares of QED Bioscience Inc. Total cost of the acquisition, including transaction costs, is SEK 20 million QED merged with Genovis Inc.
  • The Annual General Meeting, held on May 5, 2020, elected Torben Jørgensen to serve as chairman of the Board of Directors and reelected Board members Kenth Petersson, Mikael Lönn and Lotta Ljungqvist.

 

January – June in brief

  • Net sales rose by 15 percent to SEK 26,965 (23,440) thousand. Adjusted for bioprocess sales in 2019 and acquired sales, sales growth totaled 15%.
  • Gross profit totaled SEK 24,123 (23,309) thousand.
  • Operating result before depreciation and amortization (EBITDA) totaled SEK -885 (profit 5,086) thousand and was negatively impacted by non-recurring items for acquisitions and restructuring of SEK 2.3 million.
  • Operating result totaled SEK -3,180 (profit: 3,571) thousand.
  • Comprehensive income for the six-month period totaled SEK -5, 038 (2,971) thousand
  • Comprehensive income per share, basic and diluted, totaled SEK -0.08 (0.05).

 

Comments from Fredrik Olsson, Chief Executive Officer

The coronavirus pandemic has affected society at large during the quarter, and our business operations were no exception. The pandemic has been accompanied by several unforeseen challenges that have caused us to reset and focus our resources on new circumstances. I am proud that despite these challenges, our sales continued to grow by 35% and, excluding acquired sales, we were able to achieve sales growth of 11%, given the market situation in the second quarter.

The beginning of the quarter was clearly affected by the restrictions implemented in several key markets in Europe and North America, resulting in a pronounced decline in customer activity. As more markets eased the restrictions, we saw a gradual increase in activity in May and June. In the Asian markets we’ve seen a clear recovery after a weak first quarter caused by the pandemic.

In addition to the loss of sales, the operating result was also affected by non-recurring acquisition-related costs and increased personnel costs as we added 14 people to the organization, compared with the second quarter last year. Adjusted for the acquisition-related costs, the operating loss for the quarter is SEK 0.3 million.

To date, we have launched two products this year. FabRICATOR™ MagIC, which was launched in June, is intended for simplified and parallel analysis of antibody molecules in automated systems in several parts of our customers’ value chains. The product has initially been adapted for an instrument from Thermo Fischer Scientific, associated with our collaboration agreement relating to analysis of biologicals. At the beginning of the current quarter, we launched our second product for the year, GalactEXO™, a new enzyme for glycan analysis of proteins, and we still intend to launch more products during the second half of the year.

During the second quarter, we also closed the deal and acquired QED Bioscience. Despite the challenging market situation, QED’s activities in San Diego have achieved sales on a par with the same period the previous year and the company has been fully operational since we formally took over the business on April 29. Given the situation associated with the pandemic, we had to begin the integration process remotely, for which reason we gave top priority to fully integrating QED into our various business and reporting systems, which has now been concluded. We can now devote our full attention to implementing combined marketing and business strategies as the market situation gradually improves. 

We have intentionally chosen to lean forward into a challenging market situation and have focused our efforts and resources on our long-term strategies within automated analysis, glycomics and integration of the newly completed acquisition of QED Bioscience.

Despite these challenges and the uncertain market situation with clear limitations, including canceled marketing activities and customer meetings, which are key cornerstones in our business, my colleagues at Genovis have done an incredible job this quarter. We have also had the opportunity to welcome new employees from QED and we now have about 40 employees worldwide, working on developing and growing the business at Genovis together with our customers.

In the short term, there is still uncertainty about how quickly economies and activities in various locations can recover and how any new waves of the pandemic could affect customer activity. But in the long run, I remain confident in our ability to continue on this growth journey with Genovis through customer-driven innovation in close collaboration with our growing customer base.

2020-05-05 Genovis Communiqué from Genovis AB (publ) Annual General Meeting May 5, 2020 Pressreleaser Ladda ner | Visa Stäng
2020-05-05 Genovis Kommuniké från Årsstämman i Genovis AB (publ) den 5 maj 2020 Pressreleaser Ladda ner | Visa Stäng
2020-04-29 Genovis Genovis AB: Genovis acquires all shares in QED Bioscience Inc., San Diego, CA, USA Pressreleaser Ladda ner | Visa Stäng
2020-04-29 Genovis Genovis AB: Genovis förvärvar samtliga aktier i QED Bioscience Inc. USA Pressreleaser Ladda ner | Visa Stäng
2020-04-29 Genovis Genovis AB: Interim Report January - March 2020 Rapporter Ladda ner | Visa Stäng
2020-04-29 Genovis Genovis AB: Kvartalsrapport januari - mars 2020 Rapporter Ladda ner | Visa Stäng
2020-04-14 Genovis Genovis AB publish Annual Report 2019 Pressreleaser Ladda ner | Visa Stäng
2020-04-14 Genovis Genovis AB: Genovis årsredovisning för 2019 publicerad Pressreleaser Ladda ner | Visa Stäng
2020-04-07 Genovis Genovis AB: Redeye: Genovis - Paradigm Play Pressreleaser Visa Stäng
2020-03-30 Genovis Genovis AB: NOTICE OF ANNUAL GENERAL MEETING IN GENOVIS AB Pressreleaser Ladda ner | Visa Stäng
2020-03-30 Genovis Genovis AB: KALLELSE TILL ÅRSSTÄMMA 2020 Pressreleaser Ladda ner | Visa Stäng
2020-03-23 Genovis Genovis AB: Nomination Committee proposes Torben Jørgensen for new chairman of Genovis Pressreleaser Ladda ner | Visa Stäng
2020-03-23 Genovis Genovis AB: Valberedningen föreslår Torben Jørgensen till ny ordförande i Genovis Pressreleaser Ladda ner | Visa Stäng
2020-02-21 Genovis Genovis AB: Redeye: Genovis - Slutar aldrig att leverera Pressreleaser Visa Stäng
2020-02-20 Genovis Genovis AB: Genovis intends to acquire QED Bioscience and conduct a rights issue of SEK 50 million Pressreleaser Ladda ner | Visa Stäng
2020-02-20 Genovis Genovis AB: Genovis avser att förvärva QED Bioscience och genomför riktad emission om ca 50 MSEK Pressreleaser Ladda ner | Visa Stäng
2020-02-05 Genovis Genovis AB: Bokslutsrapport januari - december 2019 Rapporter Ladda ner | Visa Stäng
2020-02-05 Genovis Genovis AB: Year-end Report January - December 2019 Rapporter Ladda ner | Visa Stäng
2020-01-31 Genovis Genovis AB (publ) to publish 2020 reports ahead of schedule Pressreleaser Ladda ner | Visa Stäng
2020-01-31 Genovis Genovis AB (publ) tidigarelägger samtliga finansiella rapporter 2020 Pressreleaser Ladda ner | Visa Stäng
2020-01-21 Genovis Genovis AB: BioStock: Genovis nya CFO ser ljust på framtiden Pressreleaser Visa Stäng
2019-12-20 Genovis Genovis AB: COMMUNIQUÉ FROM EXTRAORDINARY GENERAL MEETING FOR GENOVIS AB (PUBL) DECEMBER 20, 2019 Pressreleaser Ladda ner | Visa Stäng
2019-12-20 Genovis Genovis AB: KOMMUNIKÉ FRÅN EXTRA BOLAGSTÄMMAN I GENOVIS AB (PUBL) DEN 20 DECEMBER 2019 Pressreleaser Ladda ner | Visa Stäng
2019-12-10 Genovis Genovis AB: Genovis launches Immobilized SialEXO[®]for efficient biopharmaceutical sample preparation Pressreleaser Ladda ner | Visa Stäng
2019-12-10 Genovis Genovis AB: Genovis lanserar Immobilized SialEXO[ ]för effektivare provbearbetning av biologiska läkemedel Pressreleaser Ladda ner | Visa Stäng
2019-12-04 Genovis Genovis AB (publ) announces Extraordinary General Meeting Pressreleaser Ladda ner | Visa Stäng
2019-12-04 Genovis Genovis AB (publ) kallar till extra bolagsstämma Pressreleaser Ladda ner | Visa Stäng
2019-11-28 Genovis Genovis AB: BioStock studiointervju: Genovis kommenterar sin Q3 rapport Pressreleaser Visa Stäng
2019-11-27 Genovis Genovis AB: Redeye: Genovis - När lugnet har lagt sig fortsätter (tillväxt-)resan Pressreleaser Visa Stäng
2019-11-21 Genovis Genovis AB: Interim Report January-September 2019 Rapporter Ladda ner | Visa Stäng
2019-11-21 Genovis Genovis AB: Delårsrapport januari - september 2019 Rapporter Ladda ner | Visa Stäng
2019-09-12 Genovis Genovis AB: Redeye: Genovis - Ett potentiellt game changer case Pressreleaser Visa Stäng
2019-08-28 Genovis Genovis AB: Half-Yearly Report January - June 2019 Rapporter Ladda ner | Visa Stäng
2019-08-28 Genovis Genovis AB: Halvårsrapport januari - juni 2019 Rapporter Ladda ner | Visa Stäng
2019-08-19 Genovis Genovis AB: Genovis receives order worth about SEK 13 million Pressreleaser Ladda ner | Visa Stäng
2019-08-19 Genovis Genovis AB: Genovis erhåller order värd ca 13 miljoner kronor Pressreleaser Ladda ner | Visa Stäng
2018-11-27 Genovis Interim Report January - September 2018 Rapporter Ladda ner | Visa Stäng
2018-11-27 Genovis Delårsrapport januari - september 2018 Rapporter Ladda ner | Visa Stäng
2018-11-08 Genovis Genovis certified to ISO 9001:2015 Pressreleaser Ladda ner | Visa Stäng
2018-11-08 Genovis Genovis certifierat enligt ISO 9001:2015 Pressreleaser Ladda ner | Visa Stäng
2018-09-18 Genovis Genovis launches FabRICATOR®-HPLC for automated antibody analysis Pressreleaser Ladda ner | Visa Stäng
2018-09-18 Genovis Genovis lanserar FabRICATOR®-HPLC för automatiserad antikroppsanalys Pressreleaser Ladda ner | Visa Stäng
2018-09-04 Genovis Redeye: Genovis - Ett tillväxtcase med lönsamhet runt hörnet Pressreleaser Visa Stäng
2018-08-28 Genovis Half-Yearly Report January - June 2018 Rapporter Ladda ner | Visa Stäng
2018-08-28 Genovis Halvårsrapport januari - juni 2018 Rapporter Ladda ner | Visa Stäng
2018-07-05 Genovis Genovis further expands marketing organization Pressreleaser Ladda ner | Visa Stäng
2018-07-05 Genovis Genovis expanderar marknadsorganisationen ytterligare Pressreleaser Ladda ner | Visa Stäng
2018-05-17 Genovis Communiqué from Genovis AB (publ) Annual General Meeting May 17, 2018 Pressreleaser Ladda ner | Visa Stäng
2018-05-17 Genovis Kommuniké från Årsstämman i Genovis AB (publ) den 17 maj 2018 Pressreleaser Ladda ner | Visa Stäng
2018-05-15 Genovis Interim Report January - March 2018 Rapporter Ladda ner | Visa Stäng
2018-05-15 Genovis Kvartalsrapport januari - mars 2018 Rapporter Ladda ner | Visa Stäng
2018-04-29 Genovis Genovis carries out directed share issue to raise SEK 10.1 million for the company Pressreleaser Ladda ner | Visa Stäng
2018-04-29 Genovis Genovis genomför en riktad emission som tillför bolaget ca 10,1 MSEK Pressreleaser Ladda ner | Visa Stäng
2018-04-26 Genovis Genovis launches GlycOCATCH™ for purification of O-glycosylated proteins Pressreleaser Ladda ner | Visa Stäng
2018-04-26 Genovis Genovis lanserar GlycOCATCH™ för upprening av O-glykosylerade proteiner Pressreleaser Ladda ner | Visa Stäng
2018-04-24 Genovis Genovis strengthens its marketing organization in the US Pressreleaser Ladda ner | Visa Stäng
2018-04-24 Genovis Genovis förstärker sin marknadsorganisation i USA Pressreleaser Ladda ner | Visa Stäng
2018-04-23 Genovis Proposal to expand the Genovis Board of Directors at 2018 Annual General Meeting Pressreleaser Ladda ner | Visa Stäng
2018-04-23 Genovis Genovis styrelse föreslås utökas vid årsstämman 2018 Pressreleaser Ladda ner | Visa Stäng
2018-04-06 Genovis Genovis signs distribution agreement for South Korean market Pressreleaser Ladda ner | Visa Stäng
2018-04-06 Genovis Genovis tecknar distributionsavtal för den sydkoreanska marknaden Pressreleaser Ladda ner | Visa Stäng
2018-04-05 Genovis NOTICE OF ANNUAL GENERAL MEETING IN GENOVIS AB Pressreleaser Ladda ner | Visa Stäng
2018-04-05 Genovis KALLELSE TILL ÅRSSTÄMMA I GENOVIS AB Pressreleaser Ladda ner | Visa Stäng
2018-03-22 Genovis Redeye: Genovis - Positiva signaler inför 2018 Pressreleaser Visa Stäng
2018-02-28 Genovis Year-end Report January - December 2017 Rapporter Ladda ner | Visa Stäng
2018-02-28 Genovis Bokslutsrapport januari - december 2017 Rapporter Ladda ner | Visa Stäng
2018-02-14 Genovis Genovis AB (publ) postpone publication of the Year-end Report 2017 Pressreleaser Ladda ner | Visa Stäng
2018-02-14 Genovis Ändrat datum för Bokslutsrapporten januari-december 2017 i Genovis AB (publ) Pressreleaser Ladda ner | Visa Stäng
2018-01-22 Genovis Redeye: Genovis - Marknadsinsatser symboliserade Q3 Pressreleaser Visa Stäng
2017-12-08 Genovis Genovis signs distribution agreement in India Pressreleaser Ladda ner | Visa Stäng
2017-12-08 Genovis Genovis tecknar distributionsavtal i Indien Pressreleaser Ladda ner | Visa Stäng
2017-11-27 Genovis Interim Report January - September 2017 Rapporter Ladda ner | Visa Stäng
2017-11-27 Genovis Delårsrapport januari - september 2017 Rapporter Ladda ner | Visa Stäng
2017-11-07 Genovis Genovis signs distribution agreement with Shanghai Titan Scientific Ltd. Pressreleaser Ladda ner | Visa Stäng
2017-11-07 Genovis Genovis tecknar distributionsavtal med Shanghai Titan Scientific Ltd. Pressreleaser Ladda ner | Visa Stäng
2017-10-11 Genovis Redeye: Genovis - Fokus på Asien och nya produkter Pressreleaser Visa Stäng
2017-09-18 Genovis Genovis signs distribution agreement with Chinese Beijing Zhongyuan Ltd. Pressreleaser Ladda ner | Visa Stäng
2017-09-18 Genovis Genovis signs distribution agreement with Chinese Beijing Zhongyuan Ltd. Pressreleaser Ladda ner | Visa Stäng
2017-09-18 Genovis Genovis tecknar distributionsavtal med kinesiska Beijing Zhongyuan Ltd. Pressreleaser Ladda ner | Visa Stäng
2017-09-18 Genovis Genovis tecknar distributionsavtal med kinesiska Beijing Zhongyuan Ltd. Pressreleaser Ladda ner | Visa Stäng
2017-08-28 Genovis Half-Yearly Report January - June 2017 Rapporter Ladda ner | Visa Stäng
2017-08-28 Genovis Halvårsrapport januari - juni 2017 Rapporter Ladda ner | Visa Stäng
2017-06-09 Genovis Redeye: Genovis - Klinisk produktion nästa födkrok Pressreleaser Visa Stäng
2017-05-30 Genovis Genovis expands its product portfolio and launches three products for glycan analysis Pressreleaser Ladda ner | Visa Stäng
2017-05-30 Genovis Genovis utökar produktportföljen och lanserar tre produkter för glykananalys Pressreleaser Ladda ner | Visa Stäng
2017-05-23 Genovis Analysguiden: Nya lanseringar i fokus Pressreleaser Visa Stäng
2017-05-12 Genovis Communiqué from Genovis AB (publ) Annual General Meeting May 11, 2017 Pressreleaser Ladda ner | Visa Stäng
2017-05-12 Genovis Kommuniké från Årsstämman i Genovis AB (publ) den 11 maj 2017 Pressreleaser Ladda ner | Visa Stäng
2017-05-08 Genovis Interim report January - March 2017 Rapporter Ladda ner | Visa Stäng
2017-05-08 Genovis Kvartalsrapport januari - mars 2017 Rapporter Ladda ner | Visa Stäng
2017-05-02 Genovis Genovis expands its product portfolio and launches FabALACTICA™ Pressreleaser Ladda ner | Visa Stäng
2017-05-02 Genovis Genovis utökar produktportföljen och lanserar FabALACTICA™ Pressreleaser Ladda ner | Visa Stäng
2017-04-24 Genovis Redeye: Tillväxt till attraktivt pris i Genovis Pressreleaser Visa Stäng
2017-04-20 Genovis Genovis AB publish Annual Report 2016 Rapporter Ladda ner | Visa Stäng
2017-04-20 Genovis Genovis AB publicerar årsredovisning 2016 Rapporter Ladda ner | Visa Stäng
2017-04-10 Genovis NOTICE OF ANNUAL GENERAL MEETING IN GENOVIS AB Pressreleaser Ladda ner | Visa Stäng
2017-04-10 Genovis KALLELSE TILL ÅRSSTÄMMA I GENOVIS AB Pressreleaser Ladda ner | Visa Stäng
2017-04-10 Genovis Genovis carries out directed share issue to raise SEK 11.5 million for the company Pressreleaser Ladda ner | Visa Stäng
2017-04-10 Genovis Genovis genomför en riktad emission som tillför bolaget 11,5 MSEK Pressreleaser Ladda ner | Visa Stäng
2017-04-04 Genovis Genovis AB initiates sales of GlyCLICK™ Pressreleaser Ladda ner | Visa Stäng
2017-04-04 Genovis Genovis AB inleder försäljning av GlyCLICK™ Pressreleaser Ladda ner | Visa Stäng
2017-02-27 Genovis YEAR-END REPORT JANUARY-DECEMBER 2016 Rapporter Ladda ner | Visa Stäng
2017-02-27 Genovis BOKSLUTSKOMMUNIKÉ JANUARI - DECEMBER 2016 Rapporter Ladda ner | Visa Stäng
2017-02-16 Genovis Analysguiden: Bra utsikter syns i kursen Pressreleaser Visa Stäng
2017-02-10 Genovis Redeye - Genovis fortsätter på rätt spår Pressreleaser Visa Stäng

Kommande händelser

8 May 2017 | Kvartalsrapport 2017-Q1
11 May 2017 | Årsstämma 2016
12 May 2017 | Årligutdelning 2016
28 Aug 2017 | Kvartalsrapport 2017-Q2
27 Nov 2017 | Kvartalsrapport 2017-Q3
26 Feb 2018 | Bokslutskommuniké 2017
28 Feb 2018 | Bokslutskommuniké 2017
15 May 2018 | Kvartalsrapport 2018-Q1
17 May 2018 | Årsstämma 2017
18 May 2018 | Årligutdelning
28 Aug 2018 | Kvartalsrapport 2018-Q2
27 Nov 2018 | Kvartalsrapport 2018-Q3
26 Feb 2019 | Bokslutskommuniké 2018
8 May 2019 | Kvartalsrapport 2019-Q1
23 May 2019 | Årsstämma 2018
24 May 2019 | Årligutdelning
28 Aug 2019 | Kvartalsrapport 2019-Q2
5 Feb 2020 | Bokslutskommuniké 2019
26 Feb 2020 | Bokslutskommuniké 2019
29 Apr 2020 | Kvartalsrapport 2020-Q1
5 May 2020 | Årsstämma 2019
6 May 2020 | Årligutdelning
7 May 2020 | Kvartalsrapport 2020-Q1
13 Aug 2020 | Kvartalsrapport 2020-Q2
20 Aug 2020 | Kvartalsrapport 2020-Q2
5 Nov 2020 | Kvartalsrapport 2020-Q3
10 Nov 2020 | Kvartalsrapport 2020-Q3
11 Feb 2021 | Bokslutskommuniké 2020
29 Apr 2021 | Kvartalsrapport 2021-Q1
20 May 2021 | Årsstämma 2020
21 May 2021 | Årligutdelning
12 Aug 2021 | Kvartalsrapport 2021-Q2
9 Nov 2021 | Kvartalsrapport 2021-Q3
11 Nov 2021 | Kvartalsrapport 2021-Q3

ca.penser.se använder cookies för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder cookies. Vad är cookies?

Jag godkänner